Balanced Pharma Announces Policy Against Business with Russia


Balanced Pharma Announces Policy Against Business with Russia

US-based dental anesthetic company supports Ukraine

Cornelius, North Carolina / March 15, 2022 / Balanced Pharma, Inc. (BPI) announced today that the corporation will not do business with Russian entities or affiliates as it establishes key partnerships and global manufacturing operations.

“Balanced Pharma applauds the brave citizens of Ukraine and all who fight for freedom, and we join the international community in doing our part to discourage Vladimir Putin’s criminal actions, which are an assault on worldwide freedom, stability, and human rights.” said Dr. Scott Keadle, Founder and Chief Executive Officer of BPI.

He continues, “As such, Balanced Pharma will not do business with Russian entities, their affiliates, or any who support this unjustified invasion.”

Dr. Keadle made the announcement with unanimous support of the organization’s leadership. 

About Balanced Pharma, Inc.

Balanced Pharma, Inc. (BPI) is a pharmaceutical company based in Cornelius, North Carolina.  We intend to reduce injection pain, speed the onset of anesthesia, and increase the success rate of local anesthetic injections by developing a pH-balanced formulation of lidocaine, the most common local anesthetic in dental and medical procedures.  Our initial product candidate is a standard syringe cartridge for use in dental procedures.

Products are currently in development, have not been approved by FDA, and are not available for sale.


Media Contact: Jason Suggs, Chief Communications Officer
Contact Us

Please acknowledge the following to continue

I acknowledge that all Balanced Pharma Incorporated (BPI) products are currently in development and have not been evaluated or approved by FDA or any other regulatory body.

Products mentioned on this website are not available for sale, distribution, or use in any jurisdiction.